By Canadian Press

Health Canada approves updated Novavax COVID-19 vaccine

Sep 19, 2024 | 1:25 PM

Health Canada has authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus.

The mRNA vaccine, called Nuvaxovid, has been reformulated to target the JN.1 subvariant of Omicron.

It will replace the previous version of the protein-based vaccine, which targeted the XBB.1.5 subvariant of Omicron.

Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current vaccine will be used during this fall’s respiratory virus season.

Earlier this week, Health Canada approved Moderna’s updated mRNA COVID vaccine.

Looped In

LOOPED IN WITH NIKKI OMEN: September 19, 2024

1h ago

One Man's Opinion

COLLINS: Time to listen to the soldiers in the trenches

10h ago

Question of the Week

Do you think BC should put more emphasis on involuntary care for those living with significant mental health and addiction issues?

Sep 16, 2024

It is still reviewing Pfizer’s updated mRNA vaccine, with a decision expected soon.

This report by The Canadian Press was first published Sept. 19, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

Nicole Ireland, The Canadian Press